Literature DB >> 29545888

Risk factors for new-onset chronic kidney disease in patients who have received a liver transplant.

Yuehong Li1, Binbin Li1, Wei Wang1, Jiaxuan Lv1.   

Abstract

The aim of the present study was to analyze the risk factors for new-onset chronic kidney disease (CKD) in patients who have received a liver transplant. A total of 190 patients who underwent liver transplantation between March 2001 and January 2015 were followed up, and analyzed retrospectively. Sex, age, primary disease, preoperative laboratory findings (hemoglobin, albumin, creatinine and glomerular filtration rate), surgical approach, blood loss during the surgery and transfusion volume, postoperative complications, and the average levels of calcineurin inhibitors (CNIs) (from liver transplantation to the onset of CKD) were analyzed. In total, 40 patients developed new-onset CKD after transplantation. Clinical data in the new-onset CKD group were compared with the non-CKD group. A χ2 test, t-test and logistic regression analysis were performed using SPSS 17.0 software. The incidence of new-onset CKD after liver transplantation was 21.1%. Renal pathology included IgA nephropathy, hepatitis B virus-associated nephropathy, membranous proliferative glomerulonephritis, focal segmental glomerular sclerosis and cryoglobulinemia-associated renal injury. Among the CKD patients, 85.7% had tubulointerstitial damage. Univariate analysis showed that preoperative renal function, hemoglobin, intraoperative blood loss and transfusion volume, postoperative acute kidney injury, average levels of CNIs, and hypertension were risk factors for new-onset CKD after liver transplantation. Logistic regression analysis showed that preoperative glomerular filtration rate [odds ratio (OR)=0.980, P=0.041], hemoglobin (OR=0.972, P=0.034), average levels of CNIs (OR=1.364, P=0.015) and hypertension (OR=4.833, P=0.048)] were independent risk factors for new-onset CKD. The incidence of new-onset CKD in patients who received liver transplantation was high. The main risk factors were identified to be preoperative glomerular filtration rate, hemoglobin, postoperative average levels of CNIs and hypertension.

Entities:  

Keywords:  calcineurin inhibitors; chronic kidney disease; liver transplantation; renal pathology

Year:  2018        PMID: 29545888      PMCID: PMC5840952          DOI: 10.3892/etm.2018.5823

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  18 in total

Review 1.  Chronic Kidney Disease and Related Long-Term Complications After Liver Transplantation.

Authors:  Pratima Sharma; Khurram Bari
Journal:  Adv Chronic Kidney Dis       Date:  2015-09       Impact factor: 3.620

2.  Patient-specific prediction of ESRD after liver transplantation.

Authors:  Pratima Sharma; Nathan P Goodrich; Douglas E Schaubel; Mary K Guidinger; Robert M Merion
Journal:  J Am Soc Nephrol       Date:  2013-09-12       Impact factor: 10.121

3.  Early changes in kidney function predict long-term chronic kidney disease and mortality in patients after liver transplantation.

Authors:  Marcelo Cantarovich; Jean Tchervenkov; Steven Paraskevas; Peter Ghali; Philip Wong; Marc Deschênes; Prosanto Chaudhury; Mazen Hassanain; Dionisios Vrochides; Peter Metrakos; Jeffrey Barkun
Journal:  Transplantation       Date:  2011-12-27       Impact factor: 4.939

4.  Chronic kidney disease after nonrenal solid organ transplantation: a histological assessment and utility of chronic allograft damage index scoring.

Authors:  Chandrashekhar Kubal; Paul Cockwell; Bridget Gunson; Mark Jesky; Rajesh Hanvesakul; Vamsidhar Dronavalli; Robert S Bonser; Desley Neil
Journal:  Transplantation       Date:  2012-02-27       Impact factor: 4.939

Review 5.  Chronic kidney disease after liver transplantation: Recent evidence.

Authors:  Fabrizio Fabrizi; Vivek Dixit; Paul Martin; Piergiorgio Messa
Journal:  Int J Artif Organs       Date:  2010-11       Impact factor: 1.595

6.  A randomized, controlled study to assess the conversion from calcineurin-inhibitors to everolimus after liver transplantation--PROTECT.

Authors:  L Fischer; J Klempnauer; S Beckebaum; H J Metselaar; P Neuhaus; P Schemmer; U Settmacher; N Heyne; P-A Clavien; F Muehlbacher; I Morard; H Wolters; W Vogel; T Becker; M Sterneck; F Lehner; C Klein; G Kazemier; A Pascher; J Schmidt; F Rauchfuss; A Schnitzbauer; S Nadalin; M Hack; S Ladenburger; H J Schlitt
Journal:  Am J Transplant       Date:  2012-04-11       Impact factor: 8.086

7.  Risk of end-stage renal disease among liver transplant recipients with pretransplant renal dysfunction.

Authors:  R Ruebner; D Goldberg; P L Abt; R Bahirwani; M Levine; D Sawinski; R D Bloom; P P Reese
Journal:  Am J Transplant       Date:  2012-07-03       Impact factor: 8.086

8.  Early kidney dysfunction post liver transplantation predicts late chronic kidney disease.

Authors:  Ergun Velidedeoglu; Roy D Bloom; Michael D Crawford; Niraj M Desai; Luis Campos; Peter L Abt; Joseph W Markmann; Kevin C Mange; Kim M Olthoff; Abraham Shaked; James F Markmann
Journal:  Transplantation       Date:  2004-02-27       Impact factor: 4.939

9.  Long-term renal function after liver transplantation is related to calcineurin inhibitors blood levels.

Authors:  Isabelle Morard; Gilles Mentha; Laurent Spahr; Pietro Majno; Antoine Hadengue; Olivier Huber; Philippe Morel; Emiliano Giostra
Journal:  Clin Transplant       Date:  2006 Jan-Feb       Impact factor: 2.863

10.  Predicting end-stage renal disease after liver transplant.

Authors:  A K Israni; H Xiong; J Liu; N Salkowski; J F Trotter; J J Snyder; B L Kasiske
Journal:  Am J Transplant       Date:  2013-05-13       Impact factor: 8.086

View more
  4 in total

1.  Histologic Case Definition of an Atypical Glomerular Immune-Complex Deposition Following Kidney Transplantation.

Authors:  Kuo-Kai Chin; Vivek Charu; Michelle M O'Shaughnessy; Megan L Troxell; Xingxing S Cheng
Journal:  Kidney Int Rep       Date:  2020-02-05

2.  Prediction of chronic kidney disease after orthotopic liver transplantation: development and validation of a nomogram model.

Authors:  Dandan Guo; Huifang Wang; Jun Liu; Hang Liu; Ming Zhang; Zixuan Fu; Xuemei Liu
Journal:  BMC Nephrol       Date:  2022-01-16       Impact factor: 2.388

3.  Risk Factors and Prognosis of New-Onset Chronic Kidney Disease Following Orthotopic Liver Transplantation: A Retrospective Case-Control Study.

Authors:  Yi Duan; Zuozhi Li; Xiaoyu Wang; Lei Cui; Zhifeng Gao; Huan Zhang
Journal:  Med Sci Monit       Date:  2021-09-19

4.  The Influence of Diabetes Mellitus on the Risks of End-Stage Kidney Disease and Mortality After Liver Transplantation.

Authors:  Chung-Ying Lee; Mei-Yi Wu; Hsiu-Chen Chan; Tzu-Ting Chen; Le-Yin Hsu; Mai-Szu Wu; Yih-Giun Cherng
Journal:  Transpl Int       Date:  2022-02-07       Impact factor: 3.782

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.